<DOC>
	<DOCNO>NCT02993055</DOCNO>
	<brief_summary>A Phase I dose escalation study involve healthy subject .</brief_summary>
	<brief_title>A Study Assess Ulimorelin Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Inclusion Criteria 1 . Ethics committee approve write informed consent privacy language per national regulation must obtain subject studyrelated procedure ( include withdrawal prohibit medication , applicable ) 2 . Subject healthy male nonpregnant ( documented negative urine pregnancy test screen admission clinical study unit Day 1 SAD phase Day 3 MAD phase ) , nonlactating healthy female age 18 55 year , inclusive , weigh 50 kg 90 kg , body mass index range 18 35 kg/m2 , outside range , consider clinically significant investigator 3 . Subject nonsmoker use tobacco minimum 6 month screen ( breath carbon monoxide read ≤10 ppm screen ) 4 . Subject must willing able communicate participate whole study 5 . Must agree use adequate method contraception 1 . Subject clinically significant abnormal biochemistry , haematology urinalysis judge investigator screen admission determine investigator 2 . Subject abnormal clinically significant 12lead ECG screen admission clinical study unit period 3 . Subject 12lead ECG demonstrate QTcF &gt; 450 msec male &gt; 470 msec female screen . If QTcF exceed limit , ECG repeat 2 time least 1 minute apart , average 3 QTcF value use determine subject 's eligibility 4 . Subject know serious adverse reaction serious hypersensitivity drug formulation excipients 5 . Subjects study site employee , immediate family member study site sponsor employee 6 . Subject supine blood pressure pulse rate outside range 90 140 mmHg systolic blood pressure/40 90 mmHg diastolic blood pressure 50 90 bpm , respectively , screen admission heart rate 46 bpm predose Day 1 either SAD MAD phase 7 . Positive hepatitis B surface antigen ( HBsAg ) , hepatitis C virus antibody ( HCV Ab ) human immunodeficiency virus ( HIV ) result 8 . Subjects take , take , prescribed overthecounter drug ( 2 g per day paracetamol ) herbal remedy 7 day IMP administration 9 . Subject receive vaccine within 30 day first dose 10 . Subject history drug alcohol abuse within past 2 year screen positive result alcohol screen admission 11 . Regular alcohol consumption male &gt; 21 unit per week female &gt; 14 unit per week ( 1 unit = 1⁄2 pint beer , 25 mL 40 % spirit 125 mL glass wine ) 12 . Positive drug abuse test result 13 . Subject history clinically significant neurological , GI ( especially prior gastric oesophageal surgery , gastroparesis , peptic ulceration , GI bleeding , ulcerative colitis , Crohn 's Disease Irritable Bowel Syndrome ) , renal , hepatic , pulmonary , metabolic , cardiovascular , psychiatric , endocrine ( diabetes mellitus ) , respiratory haematological disorder disease medical condition , opinion investigator , would preclude participation study 14 . Subject participate another investigational study within past 3 month study drug administration , subject previously participate study ulimorelin 15 . Presence history clinically significant allergy require treatment , judge investigator . Hayfever allow unless active 16 . Subjects suitable vein multiple venepunctures/cannulation assess investigator screen 17 . Radiation exposure , include present study , exclude background radiation include diagnostic xrays medical exposure , exceed 5 mSv last 12 month 10 mSv last 5 year . No occupationally expose worker , define Ionising Radiation Regulations 1999 , shall participate study 18 . Donation loss great 400 mL blood within previous 3 month 19 . History upper GI surgery 20 . Acute diarrhoea constipation 7 day predict first study day . If screening occurs &gt; 7 day first study day , criterion determine first study day . Diarrhoea define passage liquid faeces and/or stool frequency great 3 time per day . Constipation define failure open bowel frequently every day 21 . Subject condition opinion investigator precludes participation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>